Blog articles

Mystery variant doubles Covid-19 severity
But how was it found, and could it help open up new avenues for treatment?

Looking back: genomics in 2021
As we approach the end of 2021, we look back on the key developments in genomics and their impact on healthcare and society

Covid-19 'neanderthal' gene variants explained
In light of new research, we revisit the role our genome plays in the severity of Covid-19 symptoms

Sequencing Covid-19: 1 million genomes
As the UK reaches a mega sequencing milestone, we look at how the data could be used to better prepare us for the future

Covid-19: susceptibility and the genome
An international collaboration has discovered new links between our genome and the variable onset and severity of Covid-19

Why mRNA vaccines aren't gene therapies
We bust another Covid-19 myth – this time about how mRNA vaccines work – in our latest blog post

Covid-19 contributes to antimicrobial resistance crisis
Covid-19 can’t be treated with antibiotics, so why are patients receiving them and what impact could this have on human health?

Genomics and the new Covid-19 variant
What do we know about the new strain of coronavirus sweeping across the UK? And how did genomics help us get there?

Key genomic technologies of 2020: fighting Covid-19
In the first of two articles reflecting on this year, we look at how genomics became central to tackling an unprecedented global pandemic

Researchers find ‘hidden’ coronavirus gene
A newly discovered gene within the genome of the SARS-CoV-2 virus could offer clues about its origins and a possible target for treatment

Covid-19: what’s in the genes?
We take a look at the latest developments in our understanding of the role of the human genome when it comes to disease severity

How genomics is changing vaccines
The speed at which a vaccine is developed can be crucial. RNA vaccines are cheaper and faster to make, but there's yet to be one licensed. Will this change with Covid-19?